The European Commission said on Wednesday it had sealed a deal with Pfizer and BioNTech to buy up to 300 million doses of the companies' COVID-19 vaccine candidate.on Monday that its experimental vaccine developed with BioNTech was more than 90% effective, making them the first drugmakers to show successful interim data from a large-scale clinical trial of a coronavirus vaccine.
Under the EU deal, the 27 EU countries could buy 200 million doses, and have an option to purchase another 100 million. The purchases could take place only after the vaccine is authorized as effective and safe by the EU drug regulator. "I'm very happy to announce today's agreement with the European company BioNTech and Pfizer to purchase 300 million doses of the vaccine," the President of the European Commission Ursula von der Leyen said.
The EU has already signed supply deals with AstraZeneca, Sanofi and Johnson & Johnson for their experimental COVID-19 shots, and is talking with Moderna, CureVac and Novavax to secure their vaccines.Do you have a personal experience with the coronavirus you'd like to share? Or a tip on how your town or community is handling the pandemic? Please emailfrom Business Insider Intelligence on how COVID-19 is affecting industries.
3rd world also suffering with covid-19
3rd also suffering with covid-19